Roanoke Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,060
| Closed | -$228K | – | 102 |
|
|
2022
Q4 | $228K | Hold |
3,060
| – | – | 0.1% | 98 |
|
|
2022
Q3 | $253K | Hold |
3,060
| – | – | 0.12% | 95 |
|
|
2022
Q2 | $291K | Hold |
3,060
| – | – | 0.13% | 92 |
|
|
2022
Q1 | $360K | Hold |
3,060
| – | – | 0.13% | 93 |
|
|
2021
Q4 | $396K | Hold |
3,060
| – | – | 0.13% | 88 |
|
|
2021
Q3 | $346K | Hold |
3,060
| – | – | 0.12% | 87 |
|
|
2021
Q2 | $317K | Hold |
3,060
| – | – | 0.11% | 90 |
|
|
2021
Q1 | $256K | Buy |
+3,060
| New | +$256K | 0.11% | 91 |
|
|
2020
Q1 | – | Sell |
-3,600
| Closed | -$280K | – | 95 |
|
|
2019
Q4 | $280K | Hold |
3,600
| – | – | 0.14% | 84 |
|
|
2019
Q3 | $264K | Hold |
3,600
| – | – | 0.12% | 88 |
|
|
2019
Q2 | $222K | Hold |
3,600
| – | – | 0.1% | 95 |
|
|
2019
Q1 | $230K | Buy |
+3,600
| New | +$230K | 0.11% | 92 |
|
|
2018
Q4 | – | Sell |
-3,600
| Closed | -$209K | – | 105 |
|
|
2018
Q3 | $209K | Buy |
+3,600
| New | +$209K | 0.09% | 99 |
|